Abstracts
The sequencing of the Epstein-Barr virus (EBV) genome (1) hopened the way to identify the complete spectrum of virus-coded proteins and to determine what controls their expression in infected cells. As the number of known viral proteins increases so one can begin to define ever more precisely the spectrum of immune response which the virus infection elicits in vivo. This catalogueing process is already well underway with respect to the anti-viral antibody response, where immunoblot analysis of serological reactivities is now complementing the original immunofluorescence methods which the pioneering work of the Henle did so much to establish. Identifying the antigenic specificity of EBV-induced T cell responses is less well advanced, but ultimately the same kind of precise analysis should be possible for the cellular response as for that mediated by antibodies. Faced with an infectious agent which can encode between 50 and 1 potential antigens, one should ask which of these many proteins are actually targets of effective immune responses i.e. those responses which have the potential either to prevent the initial virus infection or to control the numbers of virus-infected cell which accumulate in vivo.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
R. Baer et al., Nature 310, 207 (1984).
J. W. Sixbey et al., New Eng. J. Med. 310, 1225 (1984).
J. S. Greenspan et al., New Eng. J. Med. 313, 1564 (1985).
W. Henle and G. Henle, in The Epstein-Barr Virus, M. A. Epstein and B. G. Achong Eds. (Springer-Verlag, Berlin, Heidelberg, New York, 1979) pp 61–78.
G. J. Hoffman, S. G. Lazarowitz, S. D. Hayward, Proc. Natl. Acad. Sci. U.S.A. 77, 2979 (1980).
B. C. Strnad et al., J. Virol. 41, 258 (1982).
G. R. Pearson et al., J. Natl. Canc. Inst. 45, 989 (1978).
D. McGeoch, A. J. Davison, Nucleic Acids Res. 14, 4281 (1986).
P. J. Farrell, in Advancesin Viral Oncology, G. Klein Ed. (Raven Press, New York) in press.
T. Dambaugh et al., in The Epstein-Barr Virus: Recent Advances, M. A. Epstein and B. G. Achong Eds. (William Heinemann, London, 1986) pp 13–45.
J. Dillner and B. Kallin, Adv. Canc. Res. 50, 95 (1988).
G. Laux, M. Perricaudet, P. J. Farrell, EMBO J. 7, 769 (1988).
L. S. Young et al., J. Gen Virol. 69, 1051 (1988).
W. Henle et al., Proc. Natl. Acad. Sei. U.S.A. 84, 570 (1987).
G. Rhodes et al., J. Exp. Med. 165, 1026 (1987).
A. B. Rickinson, in The Epstein-Barr Virus: Recent Advances, M. A. Epstein and B. G. Achong Eds. (William Heinemann, London, 1986) pp 75–125.
G. Tosato, Adv. Canc. Res. 49, 75 (1987).
Q. Y. Yao, A. B. Rickinson, M. A. Epstein, Int. J. Cancer 35, 35 (1985).
L. A. Morrison et al., J. Exp. Med. 163, 903 (1986).
D. O. Ulaeto et al., Eur. J. Immunol. (in press).
B. Carreno, G. R. Pearson, R. J. Hartzman, (submitted for publication).
D. J. Moss et al., Eur. J. Immunol. 11, 686 (1981).
I. S. Misko et al., Int. J. Cancer 33, 239 (1984).
D. J. Moss et al., Nature 331, 719 (1988).
R. J. Murray et al., J. Virol. 62, 3747 (1988).
F. Gotch et al., J. Exp. Med. 165, 408 (1987).
A. B. Rickinson, Q. Y. Yao, L. E. Wallace, Brit. Med. Bull. 41, 75 (1985).
Q. Y. Yao et al., Int. J. Cancer, (in press).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 The Humana Press Inc.
About this chapter
Cite this chapter
Rickinson, A.B. (1989). Immune Control Mechanisms over EBV Infection. In: Ablashi, D.V., Faggioni, A., Krueger, G.R.F., Pagano, J.S., Pearson, G.R. (eds) Epstein-Barr Virus and Human Disease • 1988. Experimental Biology and Medicine, vol 20. Humana Press. https://doi.org/10.1007/978-1-4612-4508-7_25
Download citation
DOI: https://doi.org/10.1007/978-1-4612-4508-7_25
Publisher Name: Humana Press
Print ISBN: 978-1-4612-8852-7
Online ISBN: 978-1-4612-4508-7
eBook Packages: Springer Book Archive